Catherine Mazzacco
Board Member
Sight Sciences, Inc. (SGHT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Catherine Mazzacco
Catherine Mazzacco is recorded as Board Member at Sight Sciences, Inc. (SGHT). Catherine Mazzacco was last confirmed as Board Member at Krystal Biotech, Inc. (KRYS) in a filing dated April 4, 2024. Krystal Biotech, Inc. reported in an 8-K filed March 6, 2023 that Catherine Mazzacco was appointed independent member of the Board, effective March 6, 2023.
“On March 6, 2023, the Board of Directors (the "Board") of Krystal Biotech, Inc. (the "Company") approved an increase in the size of the Board from eight (8) directors to nine (9) directors and appointed Catherine Mazzacco as an independent member of the Board to fill the vacancy created by the increase in the size of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-01–present
-
2023-01-01–2024-04-04
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sight Sciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Paul Badawi CEO, Board Member
- James Rodberg CFO
- Jim Rodberg CFO
- Alison Bauerlein COO
- David Badawi CTO, Board Member
- Kashif Rashid General Counsel
- Donald Zurbay Board Member
- Gerhard Burbach Board Member
- Staffan Encrantz Board Member
- Tamara Fountain Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.